NCT02254161View on ClinicalTrials.gov

Multiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy
Interventions
DRUG

Matching placebo

Tablet

DRUG

BI 1181181 healthy elderly

Tablet

DRUG

BI 1181181 Healthy young

Tablet

Trial Locations (1)

Unknown

1344.2.1 Boehringer Ingelheim Investigational Site, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02254161 - Multiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female Volunteers | Biotech Hunter | Biotech Hunter